Blood test markers to discuss with a clinician Marker IGF-1 Why it matters Tesamorelin increases IGF-1, so this marker helps track downstream GH-axis exposure
Bibliometric analysis of the relationship between gut microbiota and chronic kidney disease from 20012022
Analysis of cassine and spectaline in the Senna sp ectabilis ethanolic extracts by capillary zone electrophoresis with indirect UV detection
Before discontinuing treatment, individuals treating obesity lost an average of 8.4% of body weight, while those treating type 2 diabetes lost an average of 4.4% of body weight
Obesity is a chronic, relapsing condition with many causes that dont just suddenly disappear when the medication stops Some 353 patients taking part in the Embla study started using semaglutide less after reaching their target weight, gradually reducing their dose to zero over an average of nine weeks
Ozempic is strictly for type 2 diabetes, involving complex care requirements that telehealth cannot meet